Verhagen PC - Search Results

1

Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis.

Burdett S, Boevé LM, Ingleby FC, Fisher DJ, Rydzewska LH, Vale CL, van Andel G, Clarke NW, Hulshof MC, James ND, Parker CC, Parmar MK, Sweeney CJ, Sydes MR, Tombal B, Verhagen PC, Tierney JF; STOPCAP M1 Radiotherapy Collaborators. Burdett S, et al. Among authors: verhagen pc. Eur Urol. 2019 Jul;76(1):115-124. doi: 10.1016/j.eururo.2019.02.003. Epub 2019 Feb 28. Eur Urol. 2019. PMID: 30826218 Free PMC article.

2

Prognostic factors in localised prostate cancer with emphasis on the application of molecular techniques.

Verhagen PC, Tilanus MG, de Weger RA, van Moorselaar RJ, van den Tweel JG, Boon TA. Verhagen PC, et al. Eur Urol. 2002 Apr;41(4):363-71. doi: 10.1016/s0302-2838(02)00048-9. Eur Urol. 2002. PMID: 12074805 Review.

3

Re: Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

Verhagen PC. Verhagen PC. Eur Urol. 2007 May;51(5):1444. doi: 10.1016/j.eururo.2007.02.022. Eur Urol. 2007. PMID: 17494121 No abstract available.

4

When to start cytotoxic therapy in asymptomatic patients with hormone refractory prostate cancer?

Hamberg P, Verhagen PC, de Wit R. Hamberg P, et al. Among authors: verhagen pc. Eur J Cancer. 2008 Jun;44(9):1193-7. doi: 10.1016/j.ejca.2008.04.005. Epub 2008 Apr 28. Eur J Cancer. 2008. PMID: 18448326 Review.

5

Reduction of serum prostate-specific antigen levels following varicella-zoster infection and valaciclovir treatment in prostate cancer.

Jurhill RR, van der Veen H, van Leenders GJ, Verhagen PC. Jurhill RR, et al. Among authors: verhagen pc. Eur Urol. 2009 Aug;56(2):392-4. doi: 10.1016/j.eururo.2009.02.025. Epub 2009 Feb 28. Eur Urol. 2009. PMID: 19278776

6

Words of wisdom. Re: Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.

Verhagen PC. Verhagen PC. Eur Urol. 2009 May;55(5):1239-40. doi: 10.1016/j.eururo.2009.01.058. Eur Urol. 2009. PMID: 19650231 No abstract available.

7

Expression of the androgen-regulated fusion gene TMPRSS2-ERG does not predict response to endocrine treatment in hormone-naïve, node-positive prostate cancer.

Boormans JL, Hermans KG, Made AC, van Leenders GJ, Wildhagen MF, Collette L, Schröder FH, Trapman J, Verhagen PC. Boormans JL, et al. Among authors: verhagen pc. Eur Urol. 2010 May;57(5):830-5. doi: 10.1016/j.eururo.2009.08.013. Epub 2009 Aug 22. Eur Urol. 2010. PMID: 19716227

8

Does local treatment of the prostate in advanced and/or lymph node metastatic disease improve efficacy of androgen-deprivation therapy? A systematic review.

Verhagen PC, Schröder FH, Collette L, Bangma CH. Verhagen PC, et al. Eur Urol. 2010 Aug;58(2):261-9. doi: 10.1016/j.eururo.2010.05.027. Epub 2010 May 27. Eur Urol. 2010. PMID: 20627403 Review.

9

Current vaccination strategies for prostate cancer.

Joniau S, Abrahamsson PA, Bellmunt J, Figdor C, Hamdy F, Verhagen P, Vogelzang NJ, Wirth M, Van Poppel H, Osanto S. Joniau S, et al. Eur Urol. 2012 Feb;61(2):290-306. doi: 10.1016/j.eururo.2011.09.020. Epub 2011 Oct 3. Eur Urol. 2012. PMID: 22001436 Review.

10

Words of wisdom. Re: Vitamin E and the risk of prostate cancer. The Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Verhagen PC. Verhagen PC. Eur Urol. 2012 Sep;62(3):565-6. doi: 10.1016/j.eururo.2012.06.021. Eur Urol. 2012. PMID: 22850202 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page